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Summary: Old male Wistar rats spontaneously showing 
hundreds of spike-wave discharges daily were used to 
investigate the role of calcium ions in nonconvulsive ep- 
ilepsy. The effects of the L-type calcium channel blocker 
nimodipine and the L-type channel opener BAY K 8644 
on number and duration of these spike-wave discharges 
were investigated. In rats aged 84-94 weeks standard 
EEG electrodes were chronically implanted; animals 
were allowed to recover for 10 days. After a baseline 
registration, nimodipine 2.2, 8.8, and 35.2 mgkg or BAY 
K 8644 in dosages of 0.12, 0.47, and 1.88 mg/kg was ad- 
ministered. A control group received the solvent. EEG 
recordings were made to evaluate drug effects. The high- 
est dose of nimodipine increased the number of spike- 
wave discharges, whereas BAY K 8644 reduced the num- 
ber of spike-wave discharges dose dependently. The high- 
est dose of BAY K 8644 also induced fatal convulsions in 
3 animals. Our results demonstrate that the L-type cal- 
cium antagonist nimodipine facilitates spike-wave dis- 
charges and that the L-type calcium agonist BAY K 8644 
protects against these discharges, in contrast to previous 
results suggesting that calcium channel blockers act as 
antiepileptic drugs (AEDs) and that calcium channel 
openers act as convulsants. Our results are a further ex- 
ample of the different pharmacologic profile of convulsive 
and nonconvulsive epilepsy and are also in contrast to 
what has been described for T-type calcium channel mod- 
ulation. We therefore propose that modulation of L-type 
and T-type calcium channels have opposite effects in non- 
convulsive epilepsy. Key Words: Absence epilepsy- 
Nimodipine-Bay K 8644-L-type calcium channels- 
Spike-wave discharges-Aged rats. 
There are several indications that calcium plays a 
role in epileptogenesis. During a seizure, the con- 
centration of intracellular calcium ions increases 
and the extracellular concentration of calcium ions 
decreases (Heinemann et al., 1977). Crowder and 
Bradford (1987) and Yaari et al. (1987) also demon- 
strated involvement of calcium, reporting that anti- 
epileptic drugs (AEDs) such as phenytoin (PHT) 
and carbamazepine (CBZ) inhibit influx of calcium 
ions. Finally, the specific antiabsence drugs etho- 
suximide (ESM) and a-methyl-a-phenylsuccinimide 
block a subtype of calcium channel, the T-type, in 
thalamic neurons (Coulter et al., 1990). Therefore, 
drugs that block influx of calcium ions into the cells 
by blocking calcium channels, calcium antagonists, 
probably have antiepileptic properties (Ashton and 
Wauquier, 1979; Hoffmeister et al., 1982; Heine- 
mann and Hamon, 1986; Meyer et al., 1987; De 
Sarro et al., 1988; Speckmann and Walden, 1989; 
Sills et al., 1994). 
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The role of calcium ions in genetic epilepsy rat 
models was confirmed by De Sarro et al. (1990), 
who showed that the calcium channel opener Bay K 
8644 facilitates convulsions in sound-induced epi- 
lepsy in genetically epilepsy-prone rats (GEPR). 
Bay K 8644, a dihydropyridine derivative, increases 
the opening probability of a particular subclass of 
calcium channels, the L-type channel, thereby pro- 
moting voltage-dependent calcium influx (Bernath, 
1992). On the other hand, nimodipine also belongs 
to the class of dihydropyridines, but this centrally 
active drug acts as a calcium antagonist by blocking 
the voltage-dependent L-type calcium channels 
(Meyer et al., 1987; Suzuki and Rogawski, 1989). 
Spedding and Paoletti (1992) suggest that BAY K 
8644 and nimodipine are rather selective for the 
L-type calcium channels. 
Among the many epilepsy models used to evalu- 
ate calcium channel modulation, models for gener- 
alized absence epilepsy are lacking. We investi- 
gated the effects of acute administration of nimo- 
dipine and Bay K 8644 on number and mean 
duration of spontaneously occurring spike-wave 
discharges in old Wistar rats. Several inbred rat 
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strains such as the WAG/Rij strain (van Luijtelaar 
and Coenen, 1986), but also selection lines such as 
Strasbourg rats (Vergnes et al., 1982) and outbred 
strains such as the Wistar and the Sprague Dawley 
strains, show an age-dependent increase in both the 
amount of spontaneously occurring spike-wave dis- 
charges and in number of affected animals (Coenen 
et al., 1992). These genetically determined spike- 
wave discharges are accompanied by minor clinical 
signs (van Luijtelaar and Coenen, 1986) and occur 
predominantly during passive wakefulness and light 
slow-wave sleep (SWS) and less during deep SWS 
and REM sleep (Coenen et al., 1991; Drinkenburg 
et al., 1991). The spike-wave discharges can be 
blocked by broad spectrum AEDs such as diazepam 
(DZP) and valproate (VPA) and also by ESM and 
trimethadion, but not by AEDs such as CBZ and 
PHT (Peeters et al., 1988). We report the effects of 
acute administration of nimodipine and BAY K 
8644 in old Wistar rats, which exhibit several hun- 
dred spontaneously occurring spike-wave dis- 
charges daily (van Luijtelaar et al., 1994). 
METHODS 
Old male random-bred Wistar rats donated by 
Troponwerke (Cologne, Germany) and originally 
purchased from Winkelmann (Borchen, Germany) 
were studied. The rats had no previous drug his- 
tory. Preoperatively , they were housed in groups 
and then were singly housed. At operation, they 
were aged 84-94 weeks and weighed 389-528 g. An- 
imals were maintained on a 12/12-h light/dark re- 
gime, with white lights on at 2000 h. 
EEG electrodes in the frontal and parietooccipital 
cortical region with coordinates A 2.0, L 3.5 and 
A-6.0, L 4.0 respectively, with skull surface flat and 
bregma zero zero, were permanently implanted un- 
der pentobarbital anaesthesia (60 mg/kg). The 
ground electrode was placed over the cerebellum. 
Postoperatively, subjects were allowed to recover 
for 10 days. 
The experiment was performed in freely moving 
animals during the dark phase of the day and drugs 
were always administered at 1100 h. In this period 
of the lighddark cycle, rats have the highest amount 
of spike-wave discharges (van Luijtelaar and Coe- 
nen, 1988). 
Nimodipine and Bay K 8644 (Bayer, Germany) 
were given intraperitoneally (i.p.) in a volume of 2 
mYkg body weight as a freshly ultrasonicated solu- 
tion in a mixture of solutol/ethanol/0.9% NaCl 
(5:5:90). The solution was prepared in a dark room 
and shielded from light. Animals were divided into 
seven groups, each consisting of 7-10 rats. They 
were connected to the recording leads 16 h before 
EEG recordings were made. Nimodipine was in- 
jected in dosages of 2.2, 8.8 and 35.2 mg/kg; Bay K 
8644 was administered in dosages of 0.12, 0.47 and 
1.88 mg/kg. In addition, we established a control 
group by injecting rats with solvent. After a 1-h 
baseline EEG recording, animals were injected i.p. 
with drugs or solvent. Subsequently, the EEG was 
recorded for 2 consecutive h. 
The EEG signal was amplified and filtered by an 
Elema-Schonander polygraph and frequencies be- 
tween 1 and 70 Hz were allowed to pass. The EEG 
was subsequently stored in digitized form on a mag- 
netooptical disk (DATA Instruments, AT-CODAS). 
Spike-wave discharges were visually scored ac- 
cording to criteria described previously (van Luijte- 
laar and Coenen, 1986). The number of spike-wave 
discharges and total duration of individual episodes 
of spike-wave discharges were determined by one 
of us (N.A.). Examples of spike-wave discharges 
are shown in Fig. 1. The number and duration of the 
spike-wave discharges were calculated for the base- 
line hour and for the four postinjection 30-min pe- 
riods. 
Spontaneous behavior of the rats in their cages 
was closely observed through a window from an 
adjacent room. We quantified duration of the fol- 
lowing behavioral categories for 30 min, beginning 5 
min after injection: exploratory behavior (walking, 
rearing, sniffing, digging), automatic behavior 
(grooming, eating, drinking), and immobile behav- 
ior (sitting, lying, and standing still) (Coenen and 
van Luijtelaar, 1989). Data were recorded and ana- 
lyzed with a PC registration software package (The 
Observer, Wageningen, NL) (Noldus, 1991). All 
data were statistically verified by analysis of vari- 
ance (ANOVA), followed by Duncan’s post hoc 
test for multiple comparisons. 
RESULTS 
All rats showed predrug spontaneously occurring 
spike-wave discharges in their cortical EEG, and 
most of the spike-wave discharges occurred during 
passive behavior. Sample records of EEGs contain- 
ing spike-wave discharges made before and after 
nimodipine and BAY K 8644 administration are 
shown in Fig. l a  and b. The effects of nimodipine 
on spike-wave discharges are shown in Fig. 2. 
There were no differences between the four groups 
before injection. Nimodipine induced an increase in 
number of spike-wave discharges in the first and 
fourth 30-min period after injection (F = 4.02, p < 
0.05 and F = 5.20, p < 0.01 respectively; both df 
3,28): post hoc tests showed that at 0-30 min after- 
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injection the group receiving 35.2 mg/kg nimodipine 
had significantly more spike-wave discharges than 
the other three groups. The same groups also dif- 
fered 90-120 min postinjection. The pooled data 0- 
120 rnin postinjection showed a significant dose ef- 
fect (F = 3.53, df 3,28, p < 0.05); again, the 35.2- 
mg/kg group showed more spike-wave discharges 
than the three other groups. 
A significant dose effect was noted for total du- 
ration of spike-wave discharges in the first, third, 
and fourth 30-min period after injection (F = 4.35, 
p < 0.05; F = 3.52, p < 0.05; and F = 8.59, p < 
0.001 respectively; all df 3,28). Post hoc tests 
showed that 0-30 rnin after administration the du- 
ration of the discharges was increased in the 35.2- 
mg/kg nimodipine group as compared with the other 
two nimodipine groups and that during the 60-90- 
min period the duration in the 35.2-mg/kg group was 
increased as compared with that of the 2.2-mg/kg 
group; finally, during the 90-120-min period, dura- 
tion of the spike-wave discharges after the highest 
dose was still enhanced as compared with that of 
the three other groups. 
Nimodipine induced a change in exploratory (F 
= 3.07, df 3,27, p < 0.05) and immobile behavior (F 
= 4.16, df 3,27, p < 0.05). Rats that received 2.2 
mg/kg drug showed significantly less exploratory 
and more immobile behavior than control rats. An- 
imals that received 35.2 mg/kg nimodipine also 
showed more immobile behavior than the control 
group. 
Results obtained after administration of Bay K 
8644 are shown in Fig. 3. There were no differences 
between the groups before injection, but there were 
clear effects of BAY K 8644 after administration. 
Bay K 8644 had signifcant effects in all four 30-min 
periods after drug administration on the number of 
spike-wave discharges (F = 6.23, df 3,30, p < 0.01; 
F = 11.99, df 3,29, p < 0.0001; F = 6.98, df 3,28, 
p < 0.01; F = 4.25, df 3,27, p < 0.05 respectively). 
Post hoc tests showed that in all four 30-min periods 
the 1.88-mg/kg group had less spike-wave dis- 
charges than the 0.12-mgkg group or the control 
goup and that the 0.47-mg/kg group had fewer 
spike-wave discharges than the control group. The 
0.12-mg/kg BAY K 8644 group also had fewer 
spike-wave discharges 30-90 rnin postinjection as 
compared with the control group. In all, a clear 
dose-dependent decrease was noted in the number 
of spike wave discharges. 
BAY K 8644 also had significant effects on total 
duration of spike-wave discharges in all four 30-min 
periods (F = 5.26, df 3,30, p < 0.01; F = 6.65, df 
3,29, p < 0.01; F = 3.68, df 3,28, p < 0.05; F = 
3.86, df 3,27, p < 0.05, respectively). Post hoc tests 
showed that in all four 30-min postinjection periods 
the duration of the spike-wave discharges was 
shorter after 1.88 mg/kg BAY K 8644 as compared 
with saline and that 0 4 0  rnin postinjection total du- 
ration was also less in rats that had received 0.47 
mg/kg as compared with saline. Finally, 30-60 rnin 
postinjection, duration of the 1.88-mg/kg group was 
also reduced as compared with that of the 0.47-mg/ 
kg group and total duration of the 0.12 mg/kg group 
was reduced as compared with saline. In all, dose 
dependency on total duration is strongly suggested 
by our data. 
Bay K 8644 increased the number of immobile (F 
= 4.87, df 3,24, p < 0.01) and exploratory (F = 
5.57, df 3,24, p < 0.01) periods at the highest dose 
only, without affecting total and mean duration of 
these behavioral categories. After the highest dose, 
only some animals showed signs of ataxia. Three of 
the 10 animals that had received 1.88 mg/kg BAY K 
8644 had fatal convulsions 35-95 rnin postinjection. 
Convulsions never occurred in the three other 
groups. The data on number and duration of dis- 
charges in these animals were included until the 
convulsions appeared on EEG. 
DISCUSSION 
All old rats exhibited spike-wave discharges. The 
discharges were of the same type and morphology 
described by other investigators in selection lines 
[in particular the Strasbourg Wistar rats (Vergnes et 
al., 1982)] or inbred [in particular the WAG/Rij 
strain (van Luijtelaar and Coenen, 1986)] or outbred 
strains of rats (Willoughby and Mackenzie, 1992). 
The number and mean duration of these discharges 
agreed with previous results obtained in the same 
outbred strain (van Luijtelaar et al., 1994). We stud- 
ied only changes in number and duration of spike- 
wave discharges; we did not quantify clinical phe- 
nomena that accompany the spike-wave discharges 
in rats as in humans. Recently, we attempted to 
evaluate the most characteristic property of ab- 
4 
FIG. 1. a: Sample recording of cortical EEG of (-1 min) of 1 rat predrug (left) and of 1 min 20 min after administration of 35.2 
mg/kg nimodipine (right). A spike-wave discharge lasting -8 s is apparent predrug. Postdrug, a long train with almost continuous 
spike-wave activity is evident. b: Sample recordings of cortical EEGs of three different rats (-1 min) predrug (left) and (-1 min) 
postdrug (right) (1.88 mg/kg BAY K 8644). First and fourth tracing are from the same rat, as are the second and fifth and the third 
and sixth. Predrug spontaneously occurring spike-wave discharges were abundant; very few occurred after BAY K 8644. Time 
scales and calibration values are different in a and b. Different scales were chosen for illustration purposes only. 
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sences, the decrease in responsiveness, in humans 
and in rats. In a time-estimation paradigm, both 
species showed a loss of perceived time in trials 
with spike-wave discharges, suggesting that in both 
humans and rats the spike-wave discharges are ac- 
companied by similarities in decrease in conscious- 
ness (van Luijtelaar et al., 1991a;1991b). This find- 
ing contributes to the validation of spike-wave dis- 
charges in rats as a model for human absence 
epilepsy. 
Our present results demonstrate that the calcium 
antagonist nimodipine tends to increase the number 
and total duration of spike-wave discharges in this 
model of nonconvulsive epilepsy. The effects of ni- 
modipine on overt behavior were mild; only an in- 
crease in passive behavior was noted. Mack and 
Gilbert (1992) noted no overt changes in rat behav- 
ior after administration of 50 mg/kg nimodipine; De 
Sarro et al. (1990), using 70.2 mg/kg, noted a reduc- 
tion in locomotor activity, mild ataxia, piloerection, 
and sedation only at that dose. The highest dose of 
nimodipine we used was higher than that commonly 
used to produce cardiovascular actions, and a de- 
crease in systemic blood pressure is common after 
systemic application of this dose of nimodipine, 
which may in turn induce behavioral immobility; 
considering the well-known relation between men- 
tal and physical activity on the one hand and spike- 
wave discharges (Coenen et al., 1991; Drinkenburg 
et al., 1991; van Luijtelaar et al., 1991b) on the 
other, one may assume that the increase in number 
of spike-wave discharges results from the increase 
in behavioral immobility induced by hypotension. 
However, two factors are not in accord with this 
notion. First, some sedation also was evident after 
the lowest dose of nimodipine and was not associ- 
ated with an effect on spike-wave discharges. Sec- 
ond, the increase induced by the antagonist is in 
accord and consistent with the decrease induced by 
the agonist. From the present experiment, we con- 
clude that Bay K 8644 reduces spike-wave dis- 
control 
2.2 mdkg nimodipine 
8,8 mgkg nirnodipine 
352 rnglkg nimodipine 
baseline post 30 post 60 post 90 post 120 
time in minutes 
FIG. 2. Number of spike-wave discharges (mean and SEM) 
during baseline and during four 30-min periods after intra- 
peritoneal administration of various doses of nimodipine 
(2.2, 8.8, and 35.2 mg/kg) and solvent. 
control 
0.12 mdkg Bay K 
0.47 mg/kg Bay K 
i,88 mg/kg Bay K 
baseline post 30 post 60 post 90 post 120 
time in minutes 
FIG. 3. Number of spike-wave discharges (mean and SEM)  
during baseline and during four 30-min periods after intra- 
peritoneal administration of various doses (0.1 2, 0.47, and 
1.88 mg/kg) of BAY K 8644 and solvent. 
charges dose dependently. The effects of Bay K 
8644 on behavior were evident only at the highest 
dose; animals changed their behavior more often. 
Duration of the various behavioral categories was 
not changed, nor were there abnormal behavioral 
patterns such as ataxia (except in 2 animals) with 
splayed hind legs, delay in the righting reflex, arch- 
ing back, and tremor. Such a pattern was described 
in GEPR rats after a much higher dose of BAY K 
8644 than that used in the present study (De Sarro et 
al., 1990). Because the mild effects on behavior 
were evident only after the highest dose and the 
effects on the number of spike-wave discharges was 
already apparent at the lowest dose, the antiepilep- 
tic action of BAY K 8644 probably is not due to its 
behavioral-activating effects. 
The protective effects of BAY K 8644 and the 
facilitatory effects of nimodipine were contrary to 
effects previously described indicating that calcium 
antagonists act like AEDs (Ashton and Wauquier, 
1979; Hoffmeister et al., 1982; Drago et al., 1986; 
Heinemann and Hamon, 1986; Hoffmeister and Tet- 
terhorn, 1986; Meyer et al., 1986,1987; De Sarro et 
al., 1988; Yuasa et al., 1989; Kamal et al., 1990). 
Moreover, agonists or channel activators such as 
BAY K 8644 act like convulsant drugs (De Sarro et 
al., 1990). A closer look at the type and nature of 
the experiments cited shows that calcium antago- 
nists are mainly effective in models for complex 
partial and generalized tonic-clonic seizures and 
also that agonists promote convulsions. De Sarro et 
al. (1990) reported that 4 of 10 GEPR showed clonic 
and tonic convulsions and, with the same dose, fatal 
convulsions indeed occurred after BAY K 8644 in 
the present experiment: 3 of 10 animals died after a 
convulsion. The near-complete blockade of spike- 
wave discharges and the increased probability for 
seizures in the same animal demonstrates that BAY 
K 8644 combines two actions: a proconvulsant ac- 
tion in convulsive epilepsy and an antiepileptic ac- 
tion in nonconvulsive epilepsy. It is of interest that 
such a two-way action of BAY K 8644 is also de- 
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scribed for a,-adrenergic agonists and GABA ago- 
nists. Such drugs also promote spike-wave dis- 
charges and inhibit convulsions. Overall, these ac- 
tions demonstrate that opposite mechanisms are 
involved in convulsive and nonconvulsive epilepsy 
(Buzsaki et al., 1991; Coenen et al., 1992). 
Spike-wave discharges are believed to result from 
interplay of thalamic oscillator and a reciprocal con- 
nection of thalamic and cortical neuronal popula- 
tions. Thalamic rhythmicy is considered to origi- 
nate from the reticular thalamic nucleus (Steriade 
and Buzsaki, 1990) or from an interaction of dorsal 
lateral parts and the reticular part of the thalamus 
(Buzsaki, 1991). The rhythmic bursting of thalamic 
neurons is specifically dependent on the T-type cal- 
cium channel, as demonstrated by many in vitro 
studies (Jahnsen and Llings, 1984; Steriade and 
Llinas, 1988; Coulter et al., 1990; Avanzini et al., 
1992). Suzuki and Rogawski (1989) showed that 
these thalamic oscillations could be blocked by 
T-type calcium channel blockers. Coulter et al. con- 
firmed the involvement of T-type channels in oscil- 
lations and in absence epilepsy by showing that 
ESM, a drug that selectively protects against ab- 
sence epilepsy, specifically inhibits T-type channels 
(Coulter et al., 1989a,1989b); thus ample evidence 
shows that T-type calcium channel blockade inhib- 
its thalamic oscillations. The present results show 
opposite effects: L-type calcium channel opening 
inhibits spike-wave discharges and L-type calcium 
channel blockade tends to facilitate spike-wave dis- 
charges. 
Nimodipine may not modulate calcium channels 
exclusively. Nimodipine may block sodium and glu- 
tamate as well as calcium-dependent potassium and 
chloride channels in a dose range that modulates 
epilepsy (Jones and Heinemann, 1987; Aicardi et 
al., 1990). Avanzini et al. (1992) suggested that 
blockade of calcium channels is the mechanism un- 
derlying inhibition of spike-wave discharges. They 
showed that cadmium, which blocks both the cal- 
cium and the calcium-dependent potassium chan- 
nels, suppressed repetitive burst discharges in vitro 
and decreased the number of spike-wave discharges 
in vivo. However, application of cadmium does not 
indicate whether blockade of calcium or blockade 
of calcium-dependent potassium channels is the 
main factor; whether nimodipine aggravates spike- 
wave discharges by blocking sodium, glutamate, or 
the calcium-dependent potassium channels should 
be investigated. A role for potassium channels in 
nonconvulsive epilepsy is supported by the results 
of Gandolfo et al. (1989), who showed that a potas- 
sium channel opener reduces spike-wave dis- 
charges in vivo. 
Our results demonstrate that L-type calcium 
channel blockade facilitates and opening of the 
L-type channels suppresses spike-wave discharges. 
We propose a differential and diametrically oppo- 
site role of T- and L-type calcium ions in absence 
epilepsy: Blockade of the T-type and activation of 
the L-type calcium channels reduces spike-wave 
activity, and activation of the T-type and blocking 
of the L-type channels facilitates spike-wave activ- 
ity. Finally, L-type modulation apparently differs in 
convulsive and in nonconvulsive epilepsy. 
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